Gérard de Pouvourville

11PUBLICATIONS
37CO-AUTHORS
Cross-sectional analysisCancer therapy (excl. chemotherapy and radiation therapy)Economic models and forecastingPacific Peoples social determinants of healthMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Mar 10, 2026
Economic burden of type 2 diabetes management in France according to clinical characteristics.

Bruno Guerci, Christèle Blanc-Bisson, Eric Vicaut

|Feb 06, 2026
Cost-Effectiveness Analysis of Second-Line Lisocabtagene Maraleucel in the Treatment of Refractory or Relapsed Large B-Cell Lymphoma.

Catherine Thieblemont, Florian Colrat, Rahma Sellami

|Nov 19, 2025
Economic analyses of freestyle libre systems for people living with diabetes: a systematic literature review.

Gerard de Pouvourville, Jack Timmons, Fleur Levrat-Guillen

|Oct 29, 2024
Quality of life of inflammatory bowel diseases patients in france with EQ-5D-5 L: the QALY-MICI study.

H Sarter, J Kirschgesner, L Beaugerie

|May 23, 2024
Public Health Impact and Cost-Effectiveness Analysis of 4-Component Meningococcal Serotype B Vaccination for Infants in France.

Gérard de Pouvourville, Manon Breau-Brunel, Véronique Loncle-Provot

|May 13, 2023
How are health technology assessment bodies responding to the assessment challenges posed by cell and gene therapy?

Michael Drummond, Oriana Ciani, Giulia Fornaro

Pageof 2

Frequent Collaborators

2 joint publications

Fleur Levrat-Guillen

1 joint publications

Nicolas H Thurin

1 joint publications

Magali Rouyer

1 joint publications

Marine Gross-Goupil